Skip to content
Delayed ~15 min

NERV MINERVA NEUROSCIENCES INC

Health Care · Russell 2000

Next earnings: not announced yet

What 5 analyst firms say about MINERVA NEUROSCIENCES INC: their latest ratings, price targets and how far the stock is from them. How it works

2.42 USD+0.12 (+5.22%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+323.6%to the avg target 10.25 USD+7.83 USD
Buy 1 · Hold 2 · Sell 0

3 rated views · 6 analyst/firm records · 5 firms

Latest report14 Aug 2026avg report date 14 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 4 reports on NERV from 4 analyst firms in the last 90 days (5 firms in the past year).

Comparing each firm's latest target with its previous one: 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Citizens JMPJason ButlerConflictConflicting reports · excluded15 Apr 202614.00 USD
H.C. WainwrightDouglas TsaoHold10 Aug 20267.00 USD
JefferiesAndrew TsaiBuy14 Aug 202610.00 USD
JefferiesBiren Amin—14 Aug 202610.00 USD
Weiss RatingsUnnamed analyst—21 Sep 2026—
Data feed RESEARCHResearch TeamHold9 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 03:42 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.